doi: 10.1089/adt.2006.029.
A high throughput luminescent assay for glycogen synthase kinase-3beta inhibitors
Affiliations
- PMID: 17355201
- DOI: 10.1089/adt.2006.029
Item in Clipboard
A high throughput luminescent assay for glycogen synthase kinase-3beta inhibitors
Assay Drug Dev Technol.
2007 Feb.
Abstract
A high throughput luminescent assay based on the Kinase-Glo() system (Promega, Madison, WI) has been developed for screening against glycogen synthase kinase-3beta (GSK-3beta). Careful optimization of assay parameters allowed us to develop a robust, reproducible, and sensitive assay. Its usefulness has been demonstrated in a high throughput screening run when screening 55,000 compounds. This campaign yielded five chemical classes of hits, including several highly potent GSK-3beta inhibitors.
Similar articles
-
Identification of novel scaffold of benzothiazepinones as non-ATP competitive glycogen synthase kinase-3β inhibitors through virtual screening.Bioorg Med Chem Lett. 2012 Dec 1;22(23):7232-6. doi: 10.1016/j.bmcl.2012.09.043. Epub 2012 Sep 23. Bioorg Med Chem Lett. 2012. PMID: 23099099
-
Identification and in vitro evaluation of new leads as selective and competitive glycogen synthase kinase-3β inhibitors through ligand and structure based drug design.J Mol Graph Model. 2014 Sep;53:31-47. doi: 10.1016/j.jmgm.2014.06.013. Epub 2014 Jul 12. J Mol Graph Model. 2014. PMID: 25064440
-
3-(7-Azaindolyl)-4-arylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3.Bioorg Med Chem Lett. 2004 Jun 21;14(12):3245-50. doi: 10.1016/j.bmcl.2004.03.090. Bioorg Med Chem Lett. 2004. PMID: 15149684
-
The role of glycogen synthase kinase-3beta in schizophrenia.Drug News Perspect. 2007 Sep;20(7):437-45. doi: 10.1358/dnp.2007.20.7.1149632. Drug News Perspect. 2007. PMID: 17992266 Review.
-
Natural products as novel scaffolds for the design of glycogen synthase kinase 3β inhibitors.Expert Opin Drug Discov. 2022 Apr;17(4):377-396. doi: 10.1080/17460441.2022.2043845. Epub 2022 Mar 9. Expert Opin Drug Discov. 2022. PMID: 35262427 Review.
Cited by
-
Computer-aided molecular design of pyrazolotriazines targeting glycogen synthase kinase 3.J Enzyme Inhib Med Chem. 2019 Dec;34(1):87-96. doi: 10.1080/14756366.2018.1530223. J Enzyme Inhib Med Chem. 2019. PMID: 30362380 Free PMC article.
-
Pharmacokinetic Profile Evaluation of Novel Combretastatin Derivative, LASSBio-1920, as a Promising Colorectal Anticancer Agent.Pharmaceutics. 2023 Apr 19;15(4):1282. doi: 10.3390/pharmaceutics15041282. Pharmaceutics. 2023. PMID: 37111767 Free PMC article.
-
Shining a light on Candida-induced epithelial damage with a luciferase reporter.mSphere. 2024 Nov 21;9(11):e0050924. doi: 10.1128/msphere.00509-24. Epub 2024 Oct 16. mSphere. 2024. PMID: 39412273 Free PMC article.
-
Triple-Target Inhibition of Cholinesterase, Amyloid Aggregation, and GSK3β to Ameliorate Cognitive Deficits and Neuropathology in the Triple-Transgenic Mouse Model of Alzheimer's Disease.Neurosci Bull. 2025 May;41(5):821-836. doi: 10.1007/s12264-025-01354-y. Epub 2025 Feb 5. Neurosci Bull. 2025. PMID: 39907971
-
Protein kinase CK-1 inhibitors as new potential drugs for amyotrophic lateral sclerosis.J Med Chem. 2014 Mar 27;57(6):2755-72. doi: 10.1021/jm500065f. Epub 2014 Mar 12. J Med Chem. 2014. PMID: 24592867 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
